#BEGIN_DRUGCARD DB03068

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
3690-10-6

# ChEBI_ID:
46938

# Chemical_Formula:
C9H12N2O5

# Chemical_IUPAC_Name:
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
A chemically stable, cytidine analog that displays anti-tumor properties.  Acts as a transition state analog inhibitor of cytidine deaminase by binding to the active size as covalent hydrates.  Also shown to inhibit DNA methylation and tumor growth both in vitro and in vivo.

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Zebularine

# HET_ID:
Z

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C9H12N2O5/c12-4-5-6(13)7(14)8(16-5)11-3-1-2-10-9(11)15/h1-3,5-8,12-14H,4H2/t5-,6-,7-,8-/m1/s1

# InChI_Key:
InChIKey=RPQZTTQVRYEKCR-WCTZXXKLSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3068

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
228.202

# Molecular_Weight_Mono:
228.074621504

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1CTU

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.3

# Predicted_LogS:
-0.59

# Predicted_Water_Solubility:
5.82e+01 g/l

# Primary_Accession_No:
DB03068

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
100016

# PubChem_Substance_ID:
46504541

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT03280

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC=NC1=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
1-beta-D-ribofuranosyl-2(1H)-pyrimidinone
1-beta-D-ribofuranosylpyrimidin-2(1H)-one
DHZ
Pyrimidin-2-one beta-D-ribofuranoside
Pyrimidin-2-one ribonucleoside
pyrimidin-2-one beta-ribofuranoside

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:53 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M60916

# Drug_Target_1_GenBank_ID_Protein:
145470

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
cdd

# Drug_Target_1_Gene_Sequence:
>885 bp
ATGCATCCACGTTTTCAAACCGCTTTTGCCCAACTTGCGGATAACTTGCAATCTGCACTG
GAACCTATTCTGGCAGACAAGTACTTCCCCGCTTTGTTGACCGGGGAGCAAGTCTCATCG
CTGAAGAGCGCAACGGGGCTGGACGAAGACGCGCTGGCATTCGCACTACTTCCGCTGGCG
GCGGCCTGTGCGCGTACGCCATTGTCGAATTTTAATGTTGGCGCAATTGCGCGCGGTGTG
AGCGGAACCTGGTATTTCGGTGCCAATATGGAATTTATTGGTGCGACAATGCAGCAAACC
GTTCATGCCGAACAAAGCGCGATCAGCCACGCCTGGTTGAGTGGTGAAAAAGCGCTTGCA
GCCATCACCGTTAACTACACGCCTTGTGGTCACTGCCGTCAGTTTATGAATGAACTGAAC
AGCGGTCTGGATCTGCGTATTCATCTGCCGGGCCGCGAGGCACACGCGCTGCGTGACTAT
CTGCCAGATGCCTTTGGGCCGAAAGATCTGGAGATTAAAACGCTGCTGATGGACGAACAG
GATCACGGCTATGCGCTGACGGGTGATGCGCTTTCTCAGGCAGCGATTGCGGCGGCAAAC
CGTTCGCACATGCCTTACAGTAAGTCGCCAAGCGGTGTCGCGCTGGAATGTAAAGACGGT
CGTATTTTCAGTGGCAGCTACGCTGAAAACGCCGCATTCAACCCGACTCTGCCACCGTTG
CAGGGAGCGTTAATTCTGTTGAATCTCAAGGGTTATGATTACCCGGATATCCAGCGCGCG
GTTCTGGCAGAAAAAGCCGATGCGCCGTTGATTCAGTGGGATGCCACCTCCGCAACGCTG
AAAGCTCTCGGCTGTCACAGTATCGACCGAGTGCTTCTCGCTTAA

# Drug_Target_1_General_Function:
Nucleotide transport and metabolism

# Drug_Target_1_General_References:
1567863	Yang C, Carlow D, Wolfenden R, Short SA: Cloning and nucleotide sequence of the Escherichia coli cytidine deaminase (ccd) gene. Biochemistry. 1992 May 5;31(17):4168-74.
2575702	Valentin-Hansen P, Holst B, Josephsen J, Hammer K, Albrechtsen B: CRP/cAMP- and CytR-regulated promoters in Escherichia coli K12: the cdd promoter. Mol Microbiol. 1989 Oct;3(10):1385-90.
2692708	Frick L, Yang C, Marquez VE, Wolfenden R: Binding of pyrimidin-2-one ribonucleoside by cytidine deaminase as the transition-state analogue 3,4-dihydrouridine and the contribution of the 4-hydroxyl group to its binding affinity. Biochemistry. 1989 Nov 28;28(24):9423-30.
8289286	Betts L, Xiang S, Short SA, Wolfenden R, Carter CW Jr: Cytidine deaminase. The 2.3 A crystal structure of an enzyme: transition-state analog complex. J Mol Biol. 1994 Jan 14;235(2):635-56.
8506346	Henzel WJ, Billeci TM, Stults JT, Wong SC, Grimley C, Watanabe C: Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases. Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5011-5.
8550448	Rida S, Caillet J, Alix JH: Amplification of a novel gene, sanA, abolishes a vancomycin-sensitive defect in Escherichia coli. J Bacteriol. 1996 Jan;178(1):94-102.
8634261	Xiang S, Short SA, Wolfenden R, Carter CW Jr: Cytidine deaminase complexed to 3-deazacytidine: a "valence buffer" in zinc enzyme catalysis. Biochemistry. 1996 Feb 6;35(5):1335-41.
8899705	Gonzalez-Gil G, Bringmann P, Kahmann R: FIS is a regulator of metabolism in Escherichia coli. Mol Microbiol. 1996 Oct;22(1):21-9.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3707

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
31540

# Drug_Target_1_Name:
Cytidine deaminase

# Drug_Target_1_Number_of_Residues:
294

# Drug_Target_1_PDB_ID:
1ALN

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00383	dCMP_cyt_deam_1
PF08211	dCMP_cyt_deam_2

# Drug_Target_1_Protein_Sequence:
>Cytidine deaminase
MHPRFQTAFAQLADNLQSALEPILADKYFPALLTGEQVSSLKSATGLDEDALAFALLPLA
AACARTPLSNFNVGAIARGVSGTWYFGANMEFIGATMQQTVHAEQSAISHAWLSGEKALA
AITVNYTPCGHCRQFMNELNSGLDLRIHLPGREAHALRDYLPDAFGPKDLEIKTLLMDEQ
DHGYALTGDALSQAAIAAANRSHMPYSKSPSGVALECKDGRIFSGSYAENAAFNPTLPPL
QGALILLNLKGYDYPDIQRAVLAEKADAPLIQWDATSATLKALGCHSIDRVLLA

# Drug_Target_1_Reaction:
cytidine + H2O = uridine + ammonia

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
This enzyme scavenge exogenous and endogenous cytidine and 2'-deoxycytidine for UMP synthesis

# Drug_Target_1_SwissProt_ID:
P0ABF6

# Drug_Target_1_SwissProt_Name:
CDD_ECOLI

# Drug_Target_1_Synonyms:
CDA
Cytidine aminohydrolase
EC 3.5.4.5

# Drug_Target_1_Theoretical_pI:
5.53

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB03068
